Tenofovir as a first line option for prophylaxis in a patient with hepatitis B virus associated nephrotic syndrome
Authors:
- Selman UnverdiSUSelman Unverdi
- Mevlut CeriMCMevlut Ceri
- Seyfettin KöklüSKSeyfettin Köklü
- Hatice UnverdiHUHatice Unverdi
- Erdem KoçakEKErdem Koçak
- Murat DuranayMDMurat Duranay
Open Access
- 1 July 2011
- journal article
- other
- Published by Elsevier in Annals of Hepatology
- Vol. 10 (3) , 372-373
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literatureClinical and Experimental Nephrology, 2009
- Hepatitis B infection as a possible cause of focal segmental glomerulosclerosis (FSGS)Clinical Nephrology, 2006
- Viral nephropathyNature Clinical Practice Nephrology, 2006
- Long-term lamivudine therapy is not reasonable for HBV-associated nephropathyNephrology Dialysis Transplantation, 2005
- Lamivudine and HBV-associated nephropathyNephrology Dialysis Transplantation, 2005